13 results on '"Tsengenes A"'
Search Results
2. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease
- Author
-
Despoina Charou, Thanasis Rogdakis, Alessia Latorrata, Maria Valcarcel, Vasileios Papadogiannis, Christina Athanasiou, Alexandros Tsengenes, Maria Anna Papadopoulou, Dimitrios Lypitkas, Matthieu D. Lavigne, Theodora Katsila, Rebecca C. Wade, M. Zameel Cader, Theodora Calogeropoulou, Achille Gravanis, and Ioannis Charalampopoulos
- Subjects
In-vitro drug testing ,Stem-cell based screening ,BDNF ,TrkB ,Neurogenesis ,iPSC ,Medicine (General) ,R5-920 ,Biochemistry ,QD415-436 - Abstract
Abstract Background Neural stem cell (NSC) proliferation and differentiation in the mammalian brain decreases to minimal levels postnatally. Nevertheless, neurogenic niches persist in the adult cortex and hippocampus in rodents, primates and humans, with adult NSC differentiation sharing key regulatory mechanisms with development. Adult neurogenesis impairments have been linked to Alzheimer’s disease (AD) pathology. Addressing these impairments by using neurotrophic factors is a promising new avenue for therapeutic intervention based on neurogenesis. However, this possibility has been hindered by technical difficulties of using in-vivo models to conduct screens, including working with scarce NSCs in the adult brain and differences between human and mouse models or ethical limitations. Methods Here, we use a combination of mouse and human stem cell models for comprehensive in-vitro characterization of a novel neurogenic compound, focusing on the brain-derived neurotrophic factor (BDNF) pathway. The ability of ENT-A011, a steroidal dehydroepiandrosterone derivative, to activate the tyrosine receptor kinase B (TrkB) receptor was tested through western blotting in NIH-3T3 cells and its neurogenic and neuroprotective action were assessed through proliferation, cell death and Amyloid-β (Aβ) toxicity assays in mouse primary adult hippocampal NSCs, mouse embryonic cortical NSCs and neural progenitor cells (NPCs) differentiated from three human induced pluripotent stem cell lines from healthy and AD donors. RNA-seq profiling was used to assess if the compound acts through the same gene network as BDNF in human NPCs. Results ENT-A011 was able to increase proliferation of mouse primary adult hippocampal NSCs and embryonic cortical NSCs, in the absence of EGF/FGF, while reducing Aβ-induced cell death, acting selectively through TrkB activation. The compound was able to increase astrocytic gene markers involved in NSC maintenance, protect hippocampal neurons from Αβ toxicity and prevent synapse loss after Aβ treatment. ENT-A011 successfully induces proliferation and prevents cell death after Aβ toxicity in human NPCs, acting through a core gene network shared with BDNF as shown through RNA-seq. Conclusions Our work characterizes a novel BDNF mimetic with preferable pharmacological properties and neurogenic and neuroprotective actions in Alzheimer’s disease via stem cell-based screening, demonstrating the promise of stem cell systems for short-listing competitive candidates for further testing.
- Published
- 2024
- Full Text
- View/download PDF
3. Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity
- Author
-
Thanasis Rogdakis, Despoina Charou, Alessia Latorrata, Eleni Papadimitriou, Alexandros Tsengenes, Christina Athanasiou, Marianna Papadopoulou, Constantina Chalikiopoulou, Theodora Katsila, Isbaal Ramos, Kyriakos C. Prousis, Rebecca C. Wade, Kyriaki Sidiropoulou, Theodora Calogeropoulou, Achille Gravanis, and Ioannis Charalampopoulos
- Subjects
neurotrophin ,TrkA neurotrophin receptor ,nerve growth factor ,Alzheimer disease ,amyloid-beta ,neurotrophin mimetic ,Biology (General) ,QH301-705.5 - Abstract
Neurotrophins are growth factors that exert important neuroprotective effects by preventing neuronal death and synaptic loss. Nerve Growth Factor (NGF) acts through the activation of its high-affinity, pro-survival TrkA and low-affinity, pro-apoptotic p75NTR receptors. NGF has been shown to slow or prevent neurodegenerative signals in Alzheimer’s Disease (AD) progression. However, its low bioavailability and its blood–brain-barrier impermeability limit the use of NGF as a potential therapeutic agent against AD. Based on our previous findings on synthetic dehydroepiandrosterone derivatives, we identified a novel NGF mimetic, named ENT-A013, which selectively activates TrkA and exerts neuroprotective, anti-amyloid-β actions. We now report the chemical synthesis, in silico modelling, metabolic stability, CYP-mediated reaction phenotyping and biological characterization of ENT-A013 under physiological and neurodegenerative conditions. We show that ENT-A013 selectively activates the TrkA receptor and its downstream kinases Akt and Erk1/2 in PC12 cells, protecting these cells from serum deprivation-induced cell death. Moreover, ENT-A013 promotes survival of primary Dorsal Root Ganglion (DRG) neurons upon NGF withdrawal and protects hippocampal neurons against Amyloid β-induced apoptosis and synaptic loss. Furthermore, this neurotrophin mimetic partially restores LTP impairment. In conclusion, ENT-A013 represents a promising new lead molecule for developing therapeutics against neurodegenerative disorders, such as Alzheimer’s Disease, selectively targeting TrkA-mediated pro-survival signals.
- Published
- 2022
- Full Text
- View/download PDF
4. FEPrepare: A Web-Based Tool for Automating the Setup of Relative Binding Free Energy Calculations
- Author
-
Dimitris Dellis, Zoe Cournia, Sandro Cosconati, Giorgio Amendola, Stamatia Zavitsanou, Alexios Chatzigoulas, Michail Papadourakis, Alexandros Tsengenes, Zavitsanou, S., Tsengenes, A., Papadourakis, M., Amendola, G., Chatzigoulas, A., Dellis, D., Cosconati, S., and Cournia, Z.
- Subjects
Scheme (programming language) ,Binding free energy ,Computer science ,Entropy ,General Chemical Engineering ,Molecular Dynamics Simulation ,Library and Information Sciences ,01 natural sciences ,Force field (chemistry) ,Computational science ,Physical Phenomena ,Set (abstract data type) ,03 medical and health sciences ,0103 physical sciences ,Web application ,Topology (chemistry) ,030304 developmental biology ,computer.programming_language ,Internet ,0303 health sciences ,010304 chemical physics ,business.industry ,General Chemistry ,Computer Science Applications ,Thermodynamics ,business ,computer ,Energy (signal processing) - Abstract
Relative binding free energy calculations in drug design are becoming a useful tool in facilitating lead binding affinity optimization in a cost- and time-efficient manner. However, they have been limited by technical challenges such as the manual creation of large numbers of input files to set up, run, and analyze free energy simulations. In this Application Note, we describe FEPrepare, a novel web-based tool, which automates the setup procedure for relative binding FEP calculations for the dual-topology scheme of NAMD, one of the major MD engines, using OPLS-AA force field topology and parameter files. FEPrepare provides the user with all necessary files needed to run a FEP/MD simulation with NAMD. FEPrepare can be accessed and used at https://feprepare.vi-seem.eu/.
- Published
- 2021
- Full Text
- View/download PDF
5. A community effort to discover small molecule SARS-CoV-2 inhibitors
- Author
-
Johannes Schimunek, Philipp Seidl, Katarina Elez, Tim Hempel, Tuan Le, Frank Noé, Simon Olsson, Lluís Raich, Robin Winter, Hatice Gokcan, Filipp Gusev, Evgeny M. Gutkin, Olexandr Isayev, Maria G. Kurnikova, Chamali H. Narangoda, Roman Zubatyuk, Ivan P. Bosko, Konstantin V. Furs, Anna D. Karpenko, Yury V. Kornoushenko, Mikita Shuldau, Artsemi Yushkevich, Mohammed B. Benabderrahmane, Patrick Bousquet-Melou, Ronan Bureau, Beatrice Charton, Bertrand C. Cirou, Gérard Gil, William J. Allen, Suman Sirimulla, Stanley Watowich, Nick A. Antonopoulos, Nikolaos E. Epitropakis, Agamemnon K. Krasoulis, Vassilis P. Pitsikalis, Stavros T. Theodorakis, Igor Kozlovskii, Anton Maliutin, Alexander Medvedev, Petr Popov, Mark Zaretckii, Hamid Eghbal-zadeh, Christina Halmich, Sepp Hochreiter, Andreas Mayr, Peter Ruch, Michael Widrich, Francois Berenger, Ashutosh Kumar, Yoshihiro Yamanishi, Kam Y.J. Zhang, Emmanuel Bengio, Yoshua Bengio, Moksh J. Jain, Maksym Korablyov, Cheng-Hao Liu, Gilles Marcou, Enrico Glaab, Kelly Barnsley, Suhasini M. Iyengar, Mary Jo Ondrechen, V. Joachim Haupt, Florian Kaiser, Michael Schroeder, Luisa Pugliese, Simone Albani, Christina Athanasiou, Andrea Beccari, Paolo Carloni, Giulia D'Arrigo, Eleonora Gianquinto, Jonas Goßen, Anton Hanke, Benjamin P. Joseph, Daria B. Kokh, Sandra Kovachka, Candida Manelfi, Goutam Mukherjee, Abraham Muñiz-Chicharro, Francesco Musiani, Ariane Nunes-Alves, Giulia Paiardi, Giulia Rossetti, S. Kashif Sadiq, Francesca Spyrakis, Carmine Talarico, Alexandros Tsengenes, Rebecca C. Wade, Conner Copeland, Jeremiah Gaiser, Daniel R. Olson, Amitava Roy, Vishwesh Venkatraman, Travis J. Wheeler, Haribabu Arthanari, Klara Blaschitz, Marco Cespugli, Vedat Durmaz, Konstantin Fackeldey, Patrick D. Fischer, Christoph Gorgulla, Christian Gruber, Karl Gruber, Michael Hetmann, Jamie E. Kinney, Krishna M. Padmanabha Das, Shreya Pandita, Amit Singh, Georg Steinkellner, Guilhem Tesseyre, Gerhard Wagner, Zi-Fu Wang, Ryan J. Yust, Dmitry S. Druzhilovskiy, Dmitry A. Filimonov, Pavel V. Pogodin, Vladimir Poroikov, Anastassia V. Rudik, Leonid A. Stolbov, Alexander V. Veselovsky, Maria De Rosa, Giada De Simone, Maria R. Gulotta, Jessica Lombino, Nedra Mekni, Ugo Perricone, Arturo Casini, Amanda Embree, D. Benjamin Gordon, David Lei, Katelin Pratt, Christopher A. Voigt, Kuang-Yu Chen, Yves Jacob, Tim Krischuns, Pierre Lafaye, Agnès Zettor, M. Luis Rodríguez, Kris M. White, Daren Fearon, Frank Von Delft, Martin A. Walsh, Dragos Horvath, Charles L. Brooks III, Babak Falsafi, Bryan Ford, Adolfo García-Sastre, Sang Yup Lee, Nadia Naffakh, Alexandre Varnek, Günter Klambauer, and Thomas M. Hermans
- Abstract
The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient small-molecule drugs that are widely available, including in low- and middle-income countries, is an ongoing challenge. In this work, we report the results of a community effort, the “Billion molecules against Covid-19 challenge”, to identify small-molecule inhibitors against SARS-CoV-2 or relevant human receptors. Participating teams used a wide variety of computational methods to screen a minimum of 1 billion virtual molecules against 6 protein targets. Overall, 31 teams participated, and they suggested a total of 639,024 potentially active molecules, which were subsequently ranked to find ‘consensus compounds’. The organizing team coordinated with various contract research organizations (CROs) and collaborating institutions to synthesize and test 878 compounds for activity against proteases (Nsp5, Nsp3, TMPRSS2), nucleocapsid N, RdRP (Nsp12 domain), and (alpha) spike protein S. Overall, 27 potential inhibitors were experimentally confirmed by binding-, cleavage-, and/or viral suppression assays and are presented here. All results are freely available and can be taken further downstream without IP restrictions. Overall, we show the effectiveness of computational techniques, community efforts, and communication across research fields (i.e., protein expression and crystallography, in silico modeling, synthesis and biological assays) to accelerate the early phases of drug discovery.
- Published
- 2023
- Full Text
- View/download PDF
6. Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity
- Author
-
Rogdakis, Thanasis, primary, Charou, Despoina, additional, Latorrata, Alessia, additional, Papadimitriou, Eleni, additional, Tsengenes, Alexandros, additional, Athanasiou, Christina, additional, Papadopoulou, Marianna, additional, Chalikiopoulou, Constantina, additional, Katsila, Theodora, additional, Ramos, Isbaal, additional, Prousis, Kyriakos C., additional, Wade, Rebecca C., additional, Sidiropoulou, Kyriaki, additional, Calogeropoulou, Theodora, additional, Gravanis, Achille, additional, and Charalampopoulos, Ioannis, additional
- Published
- 2022
- Full Text
- View/download PDF
7. Coarse-Grained Molecular Dynamics Simulations of the p75 Neurotrophin Receptor Transmembrane Domain
- Author
-
Tsengenes, Alexandros, primary and Wade, Rebecca C., additional
- Published
- 2021
- Full Text
- View/download PDF
8. Coarse-Grained Molecular Dynamics Simulations of the p75 Neurotrophin Receptor Transmembrane Domain
- Author
-
Rebecca C. Wade and Alexandros Tsengenes
- Subjects
0303 health sciences ,03 medical and health sciences ,Transmembrane domain ,Molecular dynamics ,0302 clinical medicine ,Chemistry ,Biophysics ,Low-affinity nerve growth factor receptor ,030217 neurology & neurosurgery ,030304 developmental biology - Published
- 2021
- Full Text
- View/download PDF
9. Investigation and evaluation of multilevel H-NPC converter for electrically driven trains
- Author
-
G. Adamidis, N. Alagialoglou, and Georgios Tsengenes
- Subjects
Physics ,Renewable Energy, Sustainability and the Environment ,Energy Engineering and Power Technology ,Power factor ,Converters ,Topology ,Three level ,law.invention ,Amplitude ,law ,Harmonics ,Train ,Electrical and Electronic Engineering ,Transformer ,Simulation - Abstract
In this paper is analyzed and simulated on the computer the operation of a three level H-bridge converter as well as its parallel operations. Based on the simulation results the operating behavior between a) a three level H-bridge neutral point clamped converter, b) a three level H-bridge neutral point clamped converter with parallel elements and c) two three level H-bridge neutral point clamped converters parallel connected is being compared. From the simulation results is obvious that in the first two cases the ripples, the distortion in primary and secondary winding currents, and the power factor are quite satisfactory and almost identical to each other. In the third case as compared with the first two, we observe that current harmonics with higher amplitude appear in the primary winding of the transformer.
- Published
- 2011
- Full Text
- View/download PDF
10. Three Phase Grid Connected Photovoltaic System with Active and Reactive Power Control Using 'Instantaneous Reactive Power Theory'
- Author
-
G. Adamidis, K. Kelesidis, and Georgios Tsengenes
- Subjects
Engineering ,Renewable Energy, Sustainability and the Environment ,business.industry ,Photovoltaic system ,Energy Engineering and Power Technology ,AC power ,Grid ,Maximum power point tracking ,Three-phase ,Control theory ,Grid-connected photovoltaic power system ,Inverter ,Electrical and Electronic Engineering ,business ,Nominal power (photovoltaic) - Abstract
In this paper, a photovoltaic (P/V) system, with maximum power point tracking (MPPT), connected to a three phase grid is presented. The connection of photovoltaic system on the grid takes place in one stage using voltage source inverter (VSI). For a better utilization of the photovoltaic system, the control strategy applied is based on p-q theory. According to this strategy during sunlight the system sends active power to the grid and at the same time compensates the reactive power of the load. In case there is no sunlight (during the night for instance), the inverter only compensates the reactive power of the load. The advantage of this strategy is the operation of the photovoltaic system the whole day. In this paper the p-q theory is proposed, which does not demand the use of PLL and introduces simple algebraic calculations.
- Published
- 2010
- Full Text
- View/download PDF
11. Performance Evaluation of PI and Fuzzy Controlled Power Electronic Inverters for Power Quality Improvement
- Author
-
G. Adamidis and Georgios Tsengenes
- Subjects
Licensee ,Computer science ,Power quality ,Control engineering ,Creative commons ,Fuzzy logic ,License ,Power (physics) - Abstract
© 2012 Tsengenes and Adamidis, licensee InTech. This is an open access chapter distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Performance Evaluation of PI and Fuzzy Controlled Power Electronic Inverters for Power Quality Improvement
- Published
- 2012
- Full Text
- View/download PDF
12. Performance Evaluation of PI and Fuzzy Controlled Power Electronic Inverters for Power Quality Improvement
- Author
-
Tsengenes, Georgios A. and Adamidis, Georgios A.
- Published
- 2012
13. Three Phase Grid Connected Photovoltaic System with Active and Reactive Power Control Using “Instantaneous Reactive Power Theory”
- Author
-
Adamidis, G., primary, Tsengenes, G., additional, and Kelesidis, K., additional
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.